CANNRX
DEAD

Serial Number

86312882

Owner

CannRx Technology Inc.

Attorney

Joel N. Bock

Filing Date

Jun 18, 2014

Add to watchlist:

No watchlists yet
View on USPTO

CANNRX Trademark

Serial Number: 86312882

CANNRX is a trademark filed by CannRx Technology Inc. on June 18, 2014. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

CannRx Technology Inc. (4 trademarks)

11th Floor
New York, NY 10020

Entity Type: 03

Trademark Details

Filing Date

June 18, 2014

Registration Date

Not Registered

Goods & Services

Laboratory apparatus and instruments for use in extracting, purifying and concentrating marijuana, cannabis, hemp for use in developing medical, pharmaceutical and recreational products

Pharmaceutical products, namely, pills, powders, tinctures, liquids, mists, vapors, capsules, preparations, ointments, creams for use in treating pain, nausea, seizures, appetite disorders, dementia, psychiatric disorders, insomnia, Krohn's disease, headache, migraines, multiple sclerosis, Parkinson's, PTSD, anorexia, cancer

Biological assays for use in scientific research; biological assays for use in antibody based identification methods; kits comprising biological assays and reagents, marking agents, chemicals, test tubes, syringes for laboratory research use; kits comprising chemicals, reagents, marking agents, test tubes, syringes for use in developing pharmaceutical products

Development of research models for designing, testing and developing medical, pharmaceutical and recreational products, namely, medical marijuana, pain relief medications, cancer treatment drugs, medications for relieving nausea, medications for treating seizures, appetite disorders, dementia, psychiatric disorders, insomnia, Krohn's disease, headache, migraines, multiple sclerosis, Parkinson's, PTSD, anorexia; Consulting and laboratory services relating to testing of medical, recreational and pharmaceutical products namely, medical marijuana, pain relief medications, cancer treatment drugs, medications for relieving nausea, medications for treating seizures, appetite disorders, dementia, psychiatric disorders, insomnia, Krohn's disease, headache, migraines, multiple sclerosis, Parkinson's, PTSD, anorexia; Analysis in the nature of scientific and medical research relating to the components of natural extracts, oils, seeds, plant matter for pharmaceutical activity, byproducts, contaminants, impurities, and for use in the treatment of various diseases and medical conditions

Filing History

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Sep 30, 2015 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Sep 29, 2015 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 26, 2015 GNRN
NON-FINAL ACTION E-MAILED
Feb 26, 2015 GNRT
NON-FINAL ACTION WRITTEN
Feb 26, 2015 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 27, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 27, 2015 CRFA
ASSIGNED TO LIE
Jan 20, 2015 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 12, 2015 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 9, 2014 GNRN
NON-FINAL ACTION E-MAILED
Oct 9, 2014 GNRT
NON-FINAL ACTION WRITTEN
Oct 9, 2014 CNRT
ASSIGNED TO EXAMINER
Oct 6, 2014 DOCK
ASSIGNED TO EXAMINER
Sep 26, 2014 DOCK
NOTICE OF PSEUDO MARK E-MAILED
Jun 26, 2014 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 25, 2014 NWOS
NEW APPLICATION ENTERED
Jun 21, 2014 NWAP